Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Target Site Delivery and Residence of Nanomedicines: Application of Quantitative Systems Pharmacology.

Au JL, Abbiati RA, Wientjes MG, Lu Z.

Pharmacol Rev. 2019 Apr;71(2):157-169. doi: 10.1124/pr.118.016816. Review.

PMID:
30846487
2.

Systemic Bioequivalence Is Unlikely to Equal Target Site Bioequivalence for Nanotechnology Oncologic Products.

Au JL, Lu Z, Abbiati RA, Wientjes MG.

AAPS J. 2019 Feb 1;21(2):24. doi: 10.1208/s12248-019-0296-z.

3.

A physiologically-based model to predict individual pharmacokinetics and pharmacodynamics of remifentanil.

Cascone S, Lamberti G, Piazza O, Abbiati RA, Manca D.

Eur J Pharm Sci. 2018 Jan 1;111:20-28. doi: 10.1016/j.ejps.2017.09.028. Epub 2017 Sep 20.

PMID:
28939143
4.

A physiologically based model for tramadol pharmacokinetics in horses.

Abbiati RA, Cagnardi P, Ravasio G, Villa R, Manca D.

J Theor Biol. 2017 Sep 21;429:46-51. doi: 10.1016/j.jtbi.2017.06.028. Epub 2017 Jun 23.

5.

Engineering approaches in siRNA delivery.

Barba AA, Cascone S, Caccavo D, Lamberti G, Chiarappa G, Abrami M, Grassi G, Grassi M, Tomaiuolo G, Guido S, Brucato V, Carfì Pavia F, Ghersi G, La Carrubba V, Abbiati RA, Manca D.

Int J Pharm. 2017 Jun 20;525(2):343-358. doi: 10.1016/j.ijpharm.2017.02.032. Epub 2017 Feb 14. Review.

PMID:
28213276
6.

Chemical Engineering in the "BIO" World.

Chiarappa G, Grassi M, Abrami M, Abbiati RA, Barba AA, Boisen A, Brucato V, Ghersi G, Caccavo D, Cascone S, Caserta S, Elvassore N, Giomo M, Guido S, Lamberti G, Larobina D, Manca D, Marizza P, Tomaiuolo G, Grassi G.

Curr Drug Deliv. 2017;14(2):158-178. doi: 10.2174/1567201813666160602230550. Review.

PMID:
27264726
7.

Innovations and Improvements in Pharmacokinetic Models Based on Physiology.

Abbiati RA, Manca D.

Curr Drug Deliv. 2017;14(2):190-202. doi: 10.2174/1567201813666160524142031.

PMID:
27216546

Supplemental Content

Loading ...
Support Center